Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles

Pharmaceutical Research

Volumn 30, Issue 4, 2013, Pages 1037-1049

  Desai, Pinaki R ^a   Shah, Punit P ^a   Hayden, Patrick ^b   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b MATTEK CORPORATION   (United States)

Author keywords

cell penetrating peptides; nanostructured lipid carriers; oleic acid; percutaneous penetration pathways; polymeric nanoparticles

Indexed keywords

CELL PENETRATING PEPTIDE; DEXAMETHASONE; IBUPROFEN; NANOPARTICLE; OLEIC ACID; POLYARGININE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG PENETRATION; FLUORESCENCE; HAIR FOLLICLE; HUMAN; HUMAN CELL; MALE; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN CULTURE; SURFACE PROPERTY; SWINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DERMATITIS, ALLERGIC CONTACT; DRUG CARRIERS; HAIR FOLLICLE; IBUPROFEN; MICE; MICE, INBRED C57BL; NANOPARTICLES; OLEIC ACID; PEPTIDES; PERMEABILITY; SKIN; SKIN ABSORPTION; SWINE;

EID: 84876460606     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0939-6     Document Type: Article

References (40)

1. Meidan VM, Bonner MC, Michniak BB. Transfollicular drug delivery - is it a reality? Int J Pharm. 2005;306(1-2):1-14.
2. Lademann J, Richter H, Meinke M, Sterry W, Patzelt A. Which skin model is the most appropriate for the investigation of topically applied substances into the hair follicles? Skin Pharmacol Physiol. 2010;23(1):47-52.
3. Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 2010;27(7):247-59.
4. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2-3):165-96.
5. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives. J Control Release. 2008;125(3):193-209.
6. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1-2):1-20.
7. Papakostas D, Rancan F, Sterry W, Blume-Peytavi U, Vogt A. Nanoparticles in dermatology. Arch Dermatol Res. 2011;303(8):533-50.
8. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66(2):159-64.
9. Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A. Follicular transport route-research progress and future perspectives. Eur J Pharm Biopharm. 2009;71(2):173-80.
10. Desai PR, Shah PP, Patlolla RR, Singh M. Dermal Microdialysis Technique to Evaluate the Trafficking of Surface-Modified Lipid Nanoparticles upon Topical Application. Pharm Res. 2012;29(9):2587-600.
11. Shah PP, Desai PR, Channer D, Singh M. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers. J Control Release. 2012;161(3):735-45.
12. Patlolla RR, Desai PR, Belay K, Singh MS. Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials. 2010;31(21):5598-607.
13. Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials. 2012;33(5):1607-17.
14. Shah PP, Desai PR, Singh M. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen. J Control Release. 2012;158(2):336-45.
15. El Maghraby GM, Williams AC, Barry BW. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol. 2001;53(10):1311-22.
16. Essa EA, Bonner MC, Barry BW. Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery. J Pharm Pharmacol. 2002;54(11):1481-90.
17. Barry BW. Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev. 2002;54 Suppl 1:S31-40.
18. Grams YY, Bouwstra JA. A new method to determine the distribution of a fluorophore in scalp skin with focus on hair follicles. Pharm Res. 2002;19(3):350-4.
19. Grams YY, Whitehead L, Lamers G, Sturmann N, Bouwstra JA. On-line diffusion profile of a lipophilic model dye in different depths of a hair follicle in human scalp skin. J Invest Dermatol. 2005;125(4):775-82.
20. Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, et al. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol. 2005;125(2):264-9.
21. Patzelt A, Richter H, Buettemeyer R, Huber HJ, Blume-Peytavi U, Sterry W, et al. Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm. 2008;70(1):234-8.
22. Teichmann A, Ossadnik M, Richter H, Sterry W, Lademann J. Semiquantitative determination of the penetration of a fluorescent hydrogel formulation into the hair follicle with and without follicular closure by microparticles by means of differential stripping. Skin Pharmacol Physiol. 2006;19(2):101-5.
23. Trauer S, Lademann J, Knorr F, Richter H, Liebsch M, Rozycki C, et al. Development of an in vitro modified skin absorption test for the investigation of the follicular penetration pathway of caffeine. Skin Pharmacol Physiol. 2010;23(6):320-7.
24. Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R, et al. The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol. 2008;65(4):488-92.
25. Trauer S, Patzelt A, Otberg N, Knorr F, Rozycki C, Balizs G, et al. Permeation of topically applied caffeine through human skin - a comparison of in vivo and in vitro data. Br J Clin Pharmacol. 2009;68(2):181-6.
26. Blume-Peytavi U, Massoudy L, Patzelt A, Lademann J, Dietz E, Rasulev U, et al. Follicular and percutaneous penetration pathways of topically applied minoxidil foam. Eur J Pharm Biopharm. 2010;76(3):450-3.
27. Meidan VM. Methods for quantifying intrafollicular drug delivery: a critical appraisal. Expert Opin Drug Deliv. 2010;7(9):1095-108.
28. Mallampati R, Patlolla RR, Agarwal S, Babu RJ, Hayden P, Klausner M, et al. Evaluation of EpiDerm full thickness-300 (EFT-300) as an in vitro model for skin irritation: studies on aliphatic hydrocarbons. Toxicol In Vitro. 2010;24(2):669-76.
29. Teichmann A, Otberg N, Jacobi U, Sterry W, Lademann J. Follicular penetration: development of a method to block the follicles selectively against the penetration of topically applied substances. Skin Pharmacol Physiol. 2006;19(4):216-23.
30. Chougule MB, Patel AR, Jackson T, Singh M. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PLoS One. 2011;6(3):e17733.
31. Cohen-Avrahami M, Libster D, Aserin A, Garti N. Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery. J Phys Chem B. 2011;115(34):10189-97.
32. Afonin S, Frey A, Bayerl S, Fischer D, Wadhwani P, Weinkauf S, et al. The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes. Chemphyschem. 2006;7(10):2134-42.
33. Kumar S, Sahdev P, Perumal O, Tummala H. Identification of a novel skin penetration enhancement peptide by phage display peptide library screening. Mol Pharm. 2012;9(5):1320-30.
34. Rowat AC, Kitson N, Thewalt JL. Interactions of oleic acid and model stratum corneum membranes as seen by 2H NMR. Int J Pharm. 2006;307(2):225-31.
35. Mak WC, Patzelt A, Richter H, Renneberg R, Lai KK, Ruhl E, et al. Triggering of drug release of particles in hair follicles. J Control Release. 2012;160(3):509-14.
36. Patzelt A, Richter H, Knorr F, Schafer U, Lehr CM, Dahne L, et al. Selective follicular targeting by modification of the particle sizes. J Control Release. 2011;150(1):45-8.
37. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a + cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126(6):1316-22.
38. Wosicka H, Cal K. Targeting to the hair follicles: current status and potential. J Dermatol Sci. 2010;57(2):83-9.
39. Jung S, Otberg N, Thiede G, Richter H, Sterry W, Panzner S, et al. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol. 2006;126(8):1728-32.
40. Abdulmajed K, Heard CM. Topical delivery of retinyl ascorbate. 3. Influence of follicle sealing and skin stretching. Skin Pharmacol Physiol. 2008;21(1):46-9.